Cargando…
O-GlycNacylation Remission Retards the Progression of Non-Alcoholic Fatty Liver Disease
Non-alcoholic fatty liver disease (NAFLD) is a metabolic disease spectrum associated with insulin resistance (IR), from non-alcoholic fatty liver (NAFL) to non-alcoholic steatohepatitis (NASH), cirrhosis, and hepatocellular carcinoma (HCC). O-GlcNAcylation is a posttranslational modification, regula...
Autores principales: | Zhou, Yicheng, Li, Zhangwang, Xu, Minxuan, Zhang, Deju, Ling, Jitao, Yu, Peng, Shen, Yunfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688300/ https://www.ncbi.nlm.nih.gov/pubmed/36429065 http://dx.doi.org/10.3390/cells11223637 |
Ejemplares similares
-
Curcumin Ameliorates Nonalcoholic Fatty Liver Disease through Inhibition of O-GlcNAcylation
por: Lee, Da Eun, et al.
Publicado: (2019) -
Towards clinical application of GlycA and GlycB for early detection of inflammation associated with (pre)diabetes and cardiovascular disease: recent evidence and updates
por: Fung, Erik, et al.
Publicado: (2023) -
GlycA: Evaluation of a New Biomarker of Acute Pancreatitis
por: Shah, Ishani, et al.
Publicado: (2023) -
Mass Spectrometry for O-GlcNAcylation
por: Yin, Ruoting, et al.
Publicado: (2021) -
The role of O-GlcNAcylation in development
por: Czajewski, Ignacy, et al.
Publicado: (2023)